Under the current centralized system, drug development happens in silos.
Pharmaceutical companies don’t share information. Scientists run the same failed experiments over and over again. And the process of bringing a drug to market typically takes ten-plus years.
But Paul Kohlhaas and Tyler Golato are building a new way to do drug development. A system that allows for collaboration and dramatically increases the speed of breakthroughs in healthcare.
CEO Paul and CSO Tyler are the Cofounders of Molecule, a decentralized biotech protocol that establishes a Web3 marketplace for research-related intellectual property.
On this episode of Boost VC, Paul and Tyler join us to explain how their personal experiences with the failures of healthcare inspired their interest in changing the system.
They discuss Molecule's end-to-end ecosystem for bringing drugs to market, describing how their IP-NFT both protects innovation and makes it more open, sharable and collaborative.
Listen in for insight on Eroom's Law and learn how open science leads to enormous efficiency gains in the drug development process.
Topics Covered
How Paul & Tyler define science
- Empirical discovery of knowledge
- Progressive search for truth
What inspired Paul & Tyler’s interest in science
- Personal experience with failures of healthcare
- Potential for DeSci to foster new behaviors
Paul & Tyler’s failed experiment with crowdfunding
- Tried to raise money for microdosing study
- Partnership with University of Toronto
How Molecule has evolved since 2019
- Ecosystem for bringing drugs to market
- IP-NFT framework for collaboration
How to make scientists more open to sharing
- Improve user experience
- Streamline funding process
The power of Molecule’s IP-NFT framework
- Intellectual property rights held on chain
- Collectively owned by patients
The value prop for open science
- Creates enormous efficiency gains
- Makes drug development much cheaper
Jack Scannel’s naming of Eroom’s Law
- Technology to discover drugs improving
- Yet drug discovery output in decline
The goals for DeSci over the next decade
- Extend quality of human health span
- Make science self-sovereign, self-aware
How Paul & Tyler define success
- Remain true to values and vision for life
- Net positive impact on every person
Connect with Paul Kohlhaas & Tyler Golato
Molecule https://www.molecule.to/
Molecule on GitHub https://github.com/moleculeprotocol
Molecule on Discord https://discord.com/invite/uAGW7K4hQU
Molecule on YouTube https://www.youtube.com/channel/UCWYW5ho3L_d0EO_a619E7RQ
Molecule on LinkedIn https://www.linkedin.com/company/molecule-protocol
Molecule on Twitter https://twitter.com/molecule_dao
Paul on Twitter https://twitter.com/paulkhls
Tyler on Twitter https://twitter.com/GolatoTyler
Resources
Linum Labs https://www.linumlabs.com/
Molecule’s Crowdfunding Experiment with the University of Toronto <
Popular Podcasts
Crime Junkie
Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by audiochuck Media Company.
24/7 News: The Latest
The latest news in 4 minutes updated every hour, every day.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.